Overview

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.
Phase:
Phase 3
Details
Lead Sponsor:
Phenomix
Collaborator:
Forest Laboratories